ACLA Aclara Biosciences, (MM)

ADVISORY: ACLARA BioSciences, Inc. to Announce Q3 2003 Financial Results On November 5, 2003 MOUNTAIN VIEW, Calif., Oct. 29 /PRNewswire-FirstCall/ -- ACLARA BioSciences will announce financial results for the third quarter ended September 30, 2003 on Wednesday November 5, 2003 after the market closes. Management will hold a conference call at 2:00 PM Pacific/5:00 PM Eastern on November 5, 2003 to discuss these results and update investors on the Company's progress. Interested parties may participate in the conference call by dialing 1-877-375-2162 in the United States (international callers dial: 1-973-582-2737). The call will also be available via live audio broadcast over the Internet on the ACLARA Investor Relations website at http://www.aclara.com/ from the Conference Calls link. For those unable to participate on the live call, a 24-hour replay will be available for seven days after the call at http://www.aclara.com/ or by calling 1-877-519-4471 (international dial: 1-973-341-3080) and giving the following pass code: 4279563, or by going to the ACLARA website and following the Conference Calls link from the Investor Relations pages. About ACLARA ACLARA BioSciences, Inc. is developing advanced tools for drug discovery, genomics, and proteomics using its proprietary eTag(TM) assay technology. The Company's products and services provide researchers with information critical to their drug discovery and development efforts, which previously was difficult or impossible to obtain. The solution-phase eTag Assay System is cost-effective, easy-to-use and flexible, and enables highly accurate, sensitive, and precise analysis of genes and/or proteins from limited biological samples. Importantly, researchers can use their existing instrument platforms to perform eTag analyses. More information on ACLARA can be obtained on the Company's web site at http://www.aclara.com/. Trademarks ACLARA BioSciences, eTag, and the ACLARA logo are trademarks of ACLARA BioSciences, Inc. DATASOURCE: ACLARA BioSciences, Inc. CONTACT: Alfred Merriweather VP, Finance and CFO, of ACLARA BioSciences, Inc., +1-650-210-1200 or Web site: http://www.aclara.com/

Copyright